Perforomist [formoterol] vs. foradil [formoterol] evaluated by inspiratory capacity and HRCT [high resolution computed tomography]
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2016
At a glance
- Drugs Formoterol; Formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 24 Oct 2008 Data will be presented at the Annual International Scientific Assembely of the American College of Chest Physicians (CHEST), 2008, as reported in a media relaese from Dey.
- 24 Sep 2008 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 31 Mar 2008 New trial record.